Rubiarbonone C inhibits platelet‐derived growth factor‐induced proliferation and migration of vascular smooth muscle cells through the focal adhesion kinase, MAPK and STAT3 Tyr705 signalling pathways
British Journal of Pharmacology2017Vol. 174(22), pp. 4140–4154
Citations Over TimeTop 10% of 2017 papers
Hyunsoo Park, Khong Trong Quan, Joo‐Hui Han, Sang‐Hyuk Jung, Do‐Hyung Lee, Eunji Jo, Tae‐Wan Lim, Kyung‐Sun Heo, MinKyun Na, Chang‐Seon Myung
Abstract
These findings suggest that rubiarbonone C inhibits the proliferation and migration of VSMCs by inhibiting the FAK, MAPK and STAT3 signalling pathways. Therefore, rubiarbonone C could be a good candidate for the treatment of cardiovascular disease.
Related Papers
- → Migration regulates cellular mechanical states(2019)27 cited
- → Constrained Adherable Area of Nanotopographic Surfaces Promotes Cell Migration through the Regulation of Focal Adhesion via Focal Adhesion Kinase/Rac1 Activation(2018)25 cited
- → Semaphorin 3A Increases FAK Phosphorylation at Focal Adhesions to Modulate MDA-MB-231 Cell Migration and Spreading on Different Substratum Concentrations(2017)22 cited
- → Role of DLC1 in Regulating Cellular and Focal Adhesion Dynamics(2013)
- Quantitation of Platelet-Derived Growth Factor Receptors in Human Arterial Smooth Muscle Cells In Vitro(1997)